India Diabetes Devices Market - Growth, Trends, and Forecasts (2020 - 2025)

The India Diabetes Devices Market is segmented by Management Devices (Insulin Pump, Insulin Cartridges, Insulin Syringes, Disposable Pens), and Monitoring Devices (Self-monitoring Blood Glucose, Continuous Glucose Monitoring).

Market Snapshot

Study Period:

2012-2025

Base Year:

2019

CAGR:

1.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Indian diabetes devices market has been estimated at USD 0.8 billion in 2019, registering a CAGR more than 1.6% during the forecast period from 2020 to 2025. Diabetes care devices are the devices used to monitor the glucose levels in the blood. The main types of diabetes care devices include glucose monitoring devices and management devices. The continuous glucose monitoring devices have become immensely popular due to the rise in technological innovations. India holds the second-largest market in the diabetes care devices market after China in the Asia-Pacific region, because of the increasing diabetes population in the country. The diabetes population in India is expected to reach 87 million by 2025.

Scope of the Report

The India Diabetes Devices Market is segmented by management devices (insulin pumps, insulin pens, and syringes) and monitoring devices (self-monitoring blood glucose and continuous glucose monitoring). The market study includes the following aspects:

Monitoring Devices
Self-monitoring Blood Glucose Devices (Value and Volume, 2012 - 2025)
Glucometer Devices
Test Strips
Lancets
Continuous Blood Glucose Monitoring (Value and Volume, 2012 - 2025)
Sensors
Durables
Management Devices
Insulin Pump (Value and Volume, 2012 - 2025)
Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Insulin Syringes (Value and Volume, 2012 - 2025)
Insulin Cartridges (Value and Volume, 2012 - 2025)
Disposable Pens (Value and Volume, 2012 - 2025)

Report scope can be customized per your requirements. Click here.

Key Market Trends

Increasing use of monitoring devices in India

Monitoring devices include self-monitoring blood glucose (SMBG) and continuous glucose monitoring devices (CGM). The SMBG segment held a major share in the India diabetes devices market and generated a revenue of USD 0.17 bn in 2019. The frequency of monitoring glucose levels depends on the type of diabetes, which varies from patient to patient. The awareness of self-monitoring of glucose levels has increased widely in India, and the market for monitoring devices is expected to see high growth in the country with a CAGR of 9% during the forecast period. Type-1 diabetic patients need to check their blood glucose levels at regular intervals to adjust the insulin dosing accordingly. The current CGM devices reduce all the finger pricking for measuring blood glucose levels. It shows a detailed representation of blood glucose patterns and tendencies than what can be achieved by conventional routine checking of glucose levels at set intervals.

To understand key trends, Download Sample Report

India recorded the second highest number of diabetes population in Asia-Pacific in 2019

In India currently, there are 76 million people suffering from diabetes and by 2025, nearly 10% of India’s population is likely to be affected by diabetes. Obesity, especially central obesity and increased visceral fat due to physical inactivity, and consumption of high-calorie/high-fat and high sugar diets are the major contributing factors for diabetes in Indians. The most prominent work culture perpetuated in the country, which includes sitting for hours in one position and eating fast food with little or no physical activity, is a significant contributor to diabetes in the working-age group, causing this rapid increase in diabetes cases in India.

To understand geography trends, Download Sample Report.

Competitive Landscape

The diabetes devices market in India includes several established global players as well as local players. For the CGM market in India, there are only few players that occupy major share in the market. However, in the SMBG market, the number of players is high and includes several local players. Some of the recent developments in the market are as follows:

  • In 2019, Roche's Accu-Chek SugarView blood glucose monitoring app received CE approval. Accu-Chek SugarView app enables the availability of relevant therapy information and support in everyday life of diabetes patients.
  • In 2019, Medtronics and Eris Lifesciences launched Gaurdian Connect in India. Guardian Connect is Continuous Glucose Monitoring System connected with smartphone displays for real-time data viewing of glucose levels, without a separate hardware monitor.

 

You can also purchase parts of this report. Do you want to check out a section wise price list?

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

    3. 4.3 Market Restraints

    4. 4.4 Industry Attractiveness - Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Monitoring Devices

      1. 5.1.1 Self-monitoring Blood Glucose Devices (Value and Volume, 2012 - 2025)

        1. 5.1.1.1 Glucometer Devices

        2. 5.1.1.2 Test Strips

        3. 5.1.1.3 Lancets

      2. 5.1.2 Continuous Blood Glucose Monitoring (Value and Volume, 2012 - 2025)

        1. 5.1.2.1 Sensors

        2. 5.1.2.2 Durables

    2. 5.2 Management Devices

      1. 5.2.1 Insulin Pump (Value and Volume, 2012 - 2025)

        1. 5.2.1.1 Insulin Pump Device

        2. 5.2.1.2 Insulin Pump Reservoir

        3. 5.2.1.3 Infusion Set

      2. 5.2.2 Insulin Syringes (Value and Volume, 2012 - 2025)

      3. 5.2.3 Insulin Cartridges (Value and Volume, 2012 - 2025)

      4. 5.2.4 Disposable Pens (Value and Volume, 2012 - 2025)

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes population (2012-2025)

    2. 6.2 Type-2 Diabetes population (2012-2025)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 Company Profiles

      1. 7.1.1 Becton and Dickenson

      2. 7.1.2 Medtronic

      3. 7.1.3 Insulet

      4. 7.1.4 Tandem

      5. 7.1.5 Ypsomed

      6. 7.1.6 Novo Nordisk

      7. 7.1.7 Sanofi

      8. 7.1.8 Eli Lilly

      9. 7.1.9 Abbottt

      10. 7.1.10 Roche

      11. 7.1.11 Lifescan (Johnson &Johnson)

      12. 7.1.12 Dexcom

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Related Reports